SUPN
Supernus Pharmaceuticals Inc
$41.92
+0.19% (+$0.08)
Volume
2.82M
52W High
$59.68
52W Low
$37.54
Market Cap
$2.50B
Next Earnings Report
Last Reported
Oct 29, 2026 Beat
Actual: $0.78
vs. Consensus: $0.34
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q3 2026
Oct 29, 2026
1-Day:
+0.19%
Q2 2026
Aug 4, 2026
1-Day:
+8.46%
Q2 2026
Aug 3, 2026
1-Day:
-5.98%
Q1 2026
May 6, 2026
1-Day:
+1.61%
5-Day:
-4.04%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $211.6M | +21.5% | 89.1% | 6.5% | -$4.1M |
| Q3'25 | $192.1M | +9.3% | 74.8% | -31.4% | -$45.1M |
| Q2'25 | $165.5M | -1.7% | 89.8% | 7.3% | $22.5M |
| Q1'25 | $149.8M | +4.3% | 89.5% | -6.9% | -$11.8M |
| Q4'24 | $174.2M | +6.0% | 85.0% | 12.3% | $15.3M |
| Q3'24 | $175.7M | +14.2% | 90.0% | 23.3% | $38.5M |
| Q2'24 | $168.3M | +24.2% | 89.4% | 13.4% | $19.9M |
| Q1'24 | $143.6M | -6.6% | 88.7% | -2.2% | $124,000 |
Company Information
Symbol
SUPN
Company
Supernus Pharmaceuticals Inc
Market Cap
$2.50B